Rapid colorimetric detection of p53 protein function using DNA-gold nanoconjugates with applications for drug discovery and cancer diagnostics.
暂无分享,去创建一个
Farid Ghadessy | Jun Li | David Lane | Yen Nee Tan | Xin Ting Zheng | D. Lane | F. Ghadessy | W. Goh | E. Assah | X. Zheng | Y. Tan | T. X. Lim | Jun Li | Enock Assah | Walter Goh | Ting Xiang Lim
[1] Jian Sun,et al. Colorimetric sandwich immunosensor for Aβ(1-42) based on dual antibody-modified gold nanoparticles , 2017 .
[2] A. Fersht,et al. Comparative binding of p53 to its promoter and DNA recognition elements. , 2005, Journal of molecular biology.
[3] Arunas Ramanavicius,et al. Magnetic gold nanoparticles in SERS-based sandwich immunoassay for antigen detection by well oriented antibodies. , 2013, Biosensors & bioelectronics.
[4] Douglas A. Bell,et al. Probing the Functional Impact of Sequence Variation on p53-DNA Interactions Using a Novel Microsphere Assay for Protein-DNA Binding with Human Cell Extracts , 2009, PLoS genetics.
[5] A. Fersht,et al. Quaternary structures of tumor suppressor p53 and a specific p53–DNA complex , 2007, Proceedings of the National Academy of Sciences.
[6] C. R. Leemans,et al. Molecular Diagnosis of Surgical Margins and Local Recurrence in Head and Neck Cancer Patients , 2004, Clinical Cancer Research.
[7] Sadia Afrin Khan,et al. Rapid and sensitive detection of cholera toxin using gold nanoparticle-based simple colorimetric and dynamic light scattering assay. , 2015, Analytica chimica acta.
[8] T. Haran,et al. Low-level p53 expression changes transactivation rules and reveals superactivating sequences , 2012, Proceedings of the National Academy of Sciences.
[9] L. Donehower. Using mice to examine p53 functions in cancer, aging, and longevity. , 2009, Cold Spring Harbor perspectives in biology.
[10] Karen H. Vousden,et al. Mutant p53 in Cancer: New Functions and Therapeutic Opportunities , 2014, Cancer cell.
[11] J. Memelink. Electrophoretic mobility shift assay for the analysis of interactions of jasmonic acid-responsive transcription factors with DNA. , 2013, Methods in molecular biology.
[12] B. Liu,et al. Hybrid sensor using gold nanoparticles and conjugated polyelectrolytes for studying sequence rule in protein-DNA interactions. , 2013, ACS applied materials & interfaces.
[13] G. Pfeifer,et al. In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation , 1997, Oncogene.
[14] D. Lane,et al. Development of a novel multiplex in vitro binding assay to profile p53-DNA interactions , 2010, Cell cycle.
[15] J. Storhoff,et al. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. , 1997, Science.
[16] Xiurong Yang,et al. Label-free colorimetric immunoassay for the simple and sensitive detection of neurogenin3 using gold nanoparticles. , 2011, Biosensors & bioelectronics.
[17] Itai Beno,et al. Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets , 2010, Nucleic acids research.
[18] E. Orlova,et al. Two p53 tetramers bind one consensus DNA response element , 2016, Nucleic acids research.
[19] A. Gronenborn,et al. Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[21] Y. Tan,et al. Study of single-stranded DNA binding protein-nucleic acids interactions using unmodified gold nanoparticles and its application for detection of single nucleotide polymorphisms. , 2011, Analytical chemistry.
[22] R H Hruban,et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.
[23] G. Lahav,et al. Constant rate of p53 tetramerization in response to DNA damage controls the p53 response , 2014, Molecular systems biology.
[24] Genxi Li,et al. Novel method to detect DNA methylation using gold nanoparticles coupled with enzyme-linkage reactions. , 2010, Analytical chemistry.
[25] K. Kinzler,et al. Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] V. Rotter,et al. Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies , 2011, Cancer Gene Therapy.
[27] A. Fersht,et al. Rescuing the function of mutant p53 , 2001, Nature Reviews Cancer.
[28] Jing Bo Zhang,et al. Analysis of p53 binding to DNA by fluorescence imaging microscopy. , 2012, Micron.
[29] D. Crothers,et al. 29 Structural and binding properties of DNA response elements bound to p53 proteins and the role of spacer sequences in p53-DNA interactions , 2015, Journal of biomolecular structure & dynamics.
[30] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[31] Markus O. Zimmermann,et al. Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53 , 2012, Journal of the American Chemical Society.
[32] J. Koch,et al. Peptide Arrays on Membrane Supports. Synthesis and Applications , 2002 .
[33] J. Shay,et al. A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.
[34] Mark R. Servos,et al. Instantaneous and quantitative functionalization of gold nanoparticles with thiolated DNA using a pH-assisted and surfactant-free route. , 2012, Journal of the American Chemical Society.
[35] O. Baffa,et al. Experimental assessment of gold nanoparticle-mediated dose enhancement in radiation therapy beams using electron spin resonance dosimetry , 2015, Physics in medicine and biology.
[36] P. Hainaut,et al. Somatic TP53 Mutations in the Era of Genome Sequencing. , 2016, Cold Spring Harbor perspectives in medicine.
[37] Frank M Boeckler,et al. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug , 2008, Proceedings of the National Academy of Sciences.
[38] Yide Mei,et al. Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression , 2013, Cell Death and Disease.
[39] L. Mao,et al. Molecular margin of surgical resections—Where do we go from here? , 2015, Cancer.
[40] E. Liu,et al. Gold-nanoparticle-based assay for instantaneous detection of nuclear hormone receptor-response elements interactions. , 2010, Analytical Chemistry.
[41] K. Vousden,et al. p53 mutations in cancer , 2013, Nature Cell Biology.
[42] Alan R. Fersht,et al. Small molecule induced reactivation of mutant p53 in cancer cells , 2013, Nucleic acids research.
[43] A. Fersht,et al. Structure–function–rescue: the diverse nature of common p53 cancer mutants , 2007, Oncogene.
[44] K. Wong,et al. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones. , 2016, Cancer research.